SCHEMBL20054618

SCHEMBL20054618

COC(=O)C1(C)OCC[C@H](C)O1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22141637 1.00 POLB (0.31) POLBMEN1KMT2A
SCHEMBL26730949 1.00 POLB (0.31) POLBMEN1KMT2A
SCHEMBL28381403 1.00 POLB (0.31) POLBMEN1KMT2A
SCHEMBL28529459 0.81 LMNA (0.33) MEN1KMT2A
SCHEMBL27813127 0.81
SCHEMBL20054632 0.79 MAPK1 (0.36)
SCHEMBL22127645 0.79 MAPK1 (0.36)
SCHEMBL20581981 0.79 MAPK1 (0.36)
SCHEMBL20054634 0.79 MAPK1 (0.36)
SCHEMBL20221108 0.78 L3MBTL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed